Libra Infusions Limited (DSE: LIBRAINFU)
Bangladesh
· Delayed Price · Currency is BDT
816.50
-12.30 (-1.48%)
At close: Feb 4, 2025
Libra Infusions Revenue
In the fiscal year ending June 30, 2019, Libra Infusions had annual revenue of 197.03M BDT with 3.31% growth. Libra Infusions had revenue of 35.15M in the quarter ending March 31, 2019, a decrease of -49.69%.
Revenue
197.03M
Revenue Growth
-19.64%
P/S Ratio
9.26
Revenue / Employee
281.88K
Employees
699
Market Cap
1.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2019 | 197.03M | 6.31M | 3.31% |
Jun 30, 2018 | 190.72M | -53.54M | -21.92% |
Jun 30, 2017 | 244.26M | 6.11M | 2.57% |
Jun 30, 2016 | 238.15M | -48.85M | -17.02% |
Jun 30, 2015 | 287.00M | 4.69M | 1.66% |
Jun 30, 2014 | Pro | Pro | Pro |
Jun 30, 2013 | Pro | Pro | Pro |
Jun 30, 2012 | Pro | Pro | Pro |
Jun 30, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grameenphone | 161.36B |
Square Pharmaceuticals PLC. | 72.27B |
British American Tobacco Bangladesh Company | 93.12B |
Robi Axiata PLC. | 101.06B |
Walton Hi-Tech Industries | 75.24B |
Bangladesh Export Import Company | 17.72B |
BRAC Bank PLC. | 54.86B |
Berger Paints Bangladesh | 27.70B |